The Lantern
At The Lantern, we provide non-dilutive capital to companies by acquiring recurring royalty streams.
Our model offers an alternative to traditional equity or debt financing — helping businesses unlock trapped value without giving up ownership or control.
We focus on sourcing and acquiring high-quality, revenue-generating IP agreements, allowing our clients to reinvest in innovation while offering investors exposure to predictable cash flows backed by real-world technology adoption.
Join us as we build a new asset class — where royalty income meets marketplace liquidity and capital fuels progress.
Investment Sectors
Agriculture
Accelerating sustainable innovations in food production, crop science, and ag-tech to meet global demands with long-term commercial value.
Clean Energy
Supporting breakthroughs in renewable power, storage, and decarbonization technologies through strategic royalty investments in climate-forward solutions.
MedTech
Enabling life-saving diagnostics, devices, and digital health tools to scale by backing royalty streams from proven medical innovations.
Pharmaceuticals
Investing in patented therapeutics and biotech advancements with established licensing—fueling the next generation of treatments and cures.
Infrastructure
Unlocking capital for critical infrastructure IP—spanning smart cities, mobility, and resilient systems—via royalty-driven financial models.
Emerging Tech
Backing cutting-edge breakthroughs in AI, quantum, blockchain, and beyond—transformative IP that shapes tomorrow’s industries today.
Contact us to learn more about our current investment opportunities.
- support@thelantern.io
Explore
© Copyright 2025. The Lantern